Here the HR for HF was the highest in subjects with CVDs, CKD, DM or related medications at baseline compared to whole cohort analysis and subjects without CVDs, CKD, DM or related medications at baseline, where the HR did not reach statistical significance.
← all excerpts
Prognostic value of NT-proANP levels on major cardiovascular outcomes in a 31-year follow-up study depends on baseline morbidity.
1
—
—